These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 19626664)

  • 21. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
    Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
    Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG; Peehl DM; Kadam PA; Lawrence DM
    Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
    Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of tristetraprolin expression by interleukin-1 beta and dexamethasone in human pulmonary epithelial cells: roles for nuclear factor-kappa B and p38 mitogen-activated protein kinase.
    King EM; Kaur M; Gong W; Rider CF; Holden NS; Newton R
    J Pharmacol Exp Ther; 2009 Aug; 330(2):575-85. PubMed ID: 19435930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
    Araki S; Omori Y; Lyn D; Singh RK; Meinbach DM; Sandman Y; Lokeshwar VB; Lokeshwar BL
    Cancer Res; 2007 Jul; 67(14):6854-62. PubMed ID: 17638896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1beta mediates proliferation and differentiation of multipotent neural precursor cells through the activation of SAPK/JNK pathway.
    Wang X; Fu S; Wang Y; Yu P; Hu J; Gu W; Xu XM; Lu P
    Mol Cell Neurosci; 2007 Nov; 36(3):343-54. PubMed ID: 17822921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
    Cheng CY; Hsieh HL; Sun CC; Lin CC; Luo SF; Yang CM
    J Cell Physiol; 2009 Apr; 219(1):183-93. PubMed ID: 19097143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.
    Samavati L; Rastogi R; Du W; Hüttemann M; Fite A; Franchi L
    Mol Immunol; 2009 May; 46(8-9):1867-77. PubMed ID: 19299019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.
    Mori S; Murakami-Mori K; Bonavida B
    Anticancer Res; 1998; 18(6A):4403-8. PubMed ID: 9891500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stretch and interleukin 1 beta: pro-labour factors with similar mitogen-activated protein kinase effects but differential patterns of transcription factor activation and gene expression.
    Sooranna SR; Engineer N; Liang Z; Bennett PR; Johnson MR;
    J Cell Physiol; 2007 Jul; 212(1):195-206. PubMed ID: 17348037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop.
    Kramer F; Torzewski J; Kamenz J; Veit K; Hombach V; Dedio J; Ivashchenko Y
    Mol Immunol; 2008 May; 45(9):2678-89. PubMed ID: 18262272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus-1 Tat protein up-regulates interleukin-6 and interleukin-8 expression in human breast cancer cells.
    Lee YW; Hirani AA; Kyprianou N; Toborek M
    Inflamm Res; 2005 Sep; 54(9):380-9. PubMed ID: 16273337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.
    Murphy C; McGurk M; Pettigrew J; Santinelli A; Mazzucchelli R; Johnston PG; Montironi R; Waugh DJ
    Clin Cancer Res; 2005 Jun; 11(11):4117-27. PubMed ID: 15930347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-modifying effects of glucosamine HCl involving regulation of metalloproteinases and chemokines activated by interleukin-1beta in human primary synovial fibroblasts.
    Lu HT; Liang YC; Sheu MT; Ho HO; Lin YT; Hsieh MS; Chen CH
    J Cell Biochem; 2008 May; 104(1):38-50. PubMed ID: 18080321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.
    Kang JH; Chang SY; Jang HJ; Kim DB; Ryu GR; Ko SH; Jeong IK; Jo YH; Kim MJ
    J Endocrinol; 2009 Jul; 202(1):65-75. PubMed ID: 19398497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.
    Yeh AH; Jeffery PL; Duncan RP; Herington AC; Chopin LK
    Clin Cancer Res; 2005 Dec; 11(23):8295-303. PubMed ID: 16322288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of VEGF (vascular endothelial growth factor) on expression of IL-8 (interleukin-8), IL-1beta and their receptors in bovine theca cells.
    Murayama C; Kaji A; Miyauchi K; Matsui M; Miyamoto A; Shimizu T
    Cell Biol Int; 2010 Apr; 34(5):531-6. PubMed ID: 20156197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 regulation of prostate cancer cell growth.
    Culig Z; Steiner H; Bartsch G; Hobisch A
    J Cell Biochem; 2005 Jun; 95(3):497-505. PubMed ID: 15838876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.